CCK1 antagonist (James Black Foundation)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameCCK1 antagonist (James Black Foundation)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholecystokinin A receptor antagonists
TargetsCholecystokinin A receptor
Therapy Area/IndicationsPancreatic DiseasesGallbladder Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJames Black Foundation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJames Black Foundation
Active IndicationsN/A
Inactive IndicationsPancreatic DiseasesGallbladder Diseases

Other Information

ATC CodeN/A
Related LinksN/A